The contrasting signals are notable: a director selling a sizable block ($1.6M) while the CFO buys a small amount ($40K). For a pre-revenue biotech with no pipeline catalysts reported in this filing, the sale appears routine — likely diversification by a director, not alarm. Monitor for any subsequent Form 4 filings that may indicate a 10b5-1 plan or upcoming milestone announcements.
Price Chart
Executive Summary
Camp4 Therapeutics Corp (CAMP) insider trading cluster shows a mixed pattern: Director Andrew Schwab sold 400,000 shares ($1.62M) on 8/27, while CFO Kelly Gold purchased 10,000 shares ($40K) on 8/31. The director sale represents ~0.68% of market cap ($238M), a modest but notable amount, while the CFO's buy is trivial at ~0.02%. As a pre-revenue biotech with strong bullish analyst consensus (92% buy), the cluster likely reflects routine portfolio rebalancing by a director and a small insider conviction buy by the CFO.
Key Financial Metrics
Key Facts
- Director Andrew Schwab sold 400,000 shares at $4.04 on 2026-08-27, proceeds of $1.62M
- CFO Kelly Gold purchased 10,000 shares at $3.96 on 2026-08-31, cost $39,600
- Net cluster value: $1.66M in sales vs $40K in buys
- Market cap ~$238M; director sale is ~0.68% of market cap
- No cash transactions (A/F/M/C/G) in this cluster; all trades are open-market
- Company is pre-clinical/pre-revenue biotech in pharmaceutical preparations sector
- Analyst consensus 92% bullish (12 Buy ratings out of 13 analysts)
Financial Impact
Director sold shares representing ~0.68% of market cap; CFO buy represents ~0.02%. Total net insider sale is ~0.66% of market cap.
Risk Factors
- Director sale may signal reduced conviction ahead of upcoming clinical data readout or financing
- Pre-revenue biotech carries fundamental dilution risk regardless of insider activity
- Small CFO buy does not offset the larger director sale in dollar terms
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CAMP-1788393045740 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 22d ago | Press Release | $4.34 $4.03 | ▼ −7.14% | ▼ −6.64% | $3.73 (−13.95%) |
Sep 2, 2026 29d ago | Insider Cluster | $4.49 $4.25 | ▼ −5.35% | ▼ −4.20% | $3.73 (−16.83%) |
Aug 21, 2026 6w ago | Insider Cluster | $4.48 $4.15 | ▲ +7.37% | ▲ +7.84% | $3.73 (+16.64%) |
Aug 13, 2026 7w ago | EFFECT | $4.50 $4.45 | ▼ −1.11% | ▲ +0.85% | $3.73 (−17.01%) |
Aug 5, 2026 8w ago | Insider Cluster | $4.50 $4.50 | · 0.00% | ▼ −1.21% | $3.73 (−17.01%) |
Aug 5, 2026 8w ago | Insider Cluster | $4.50 $4.50 | · 0.00% | ▼ −1.21% | $3.73 (−17.01%) |
Jul 27, 2026 9w ago | 8-K | $3.42 $3.45 | ▲ +0.88% | ▼ −0.20% | $3.73 (+9.20%) |
Jun 19, 2026 14w ago | Press Release | $4.20 $4.20 | · 0.00% | ▲ +2.07% | $3.73 (−11.08%) |
Jun 12, 2026 15w ago | 8-K | $3.96 $4.20 | ▲ +6.06% | ▲ +7.44% | $3.73 (−5.69%) |
Jun 11, 2026 16w ago | Institutional Cluster | $4.22 $4.14 | ▼ −1.90% | ▼ −2.33% | $3.73 (−11.50%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access